Q32 Bio Balance Sheet Health
Financial Health criteria checks 5/6
Q32 Bio has a total shareholder equity of $33.5M and total debt of $16.2M, which brings its debt-to-equity ratio to 48.5%. Its total assets and total liabilities are $124.2M and $90.7M respectively.
Key information
48.5%
Debt to equity ratio
US$16.24m
Debt
| Interest coverage ratio | n/a |
| Cash | US$107.65m |
| Equity | US$33.51m |
| Total liabilities | US$90.70m |
| Total assets | US$124.21m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: QTTB's short term assets ($111.6M) exceed its short term liabilities ($17.2M).
Long Term Liabilities: QTTB's short term assets ($111.6M) exceed its long term liabilities ($73.5M).
Debt to Equity History and Analysis
Debt Level: QTTB has more cash than its total debt.
Reducing Debt: Insufficient data to determine if QTTB's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: QTTB has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: QTTB has sufficient cash runway for 1.1 years if free cash flow continues to grow at historical rates of 11.6% each year.